NCT04673604View on ClinicalTrials.gov

From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 6, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

June 29, 2020

Conditions
GlaucomaOcular Surface Disease
Interventions
DIAGNOSTIC_TEST

Assessment of ocular surface staining (Oxford score 0-15 scale)

Corneal and conjunctiva staining will be recorded according to the Oxford grading scheme for ocular staining (0-15 score).

DRUG

mean diurnal intraocular pressure-lowering

At the end of each 6-month period patients will undergo diurnal intraocular pressure assessment with both therapies.

Trial Locations (1)

55536

University Department of Ophthalmology, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT04673604 - From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy | Biotech Hunter | Biotech Hunter